Renal Transplant Recipients
16
0
2
6
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
18.8%
3 terminated out of 16 trials
66.7%
-19.8% vs benchmark
31%
5 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study
Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients
Kidney Transplant Immunosuppressive Therapy Adherence Trial (KITE)
Implementing eHealth Interventions Into Regular Clinical Practice
Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients
RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
Selective CD28 Blockade in Renal Transplant Recipients
Envarsus XR in African American Renal Transplant Recipients
Research Study of ATG and Rituximab in Renal Transplantation
Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation
The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population
Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay
Sexual Function in Male Renal Transplant Patients
Web Based Renal Transplant Patient Medication Education
Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk